--- title: "Dr M Induscorp (519512) Financials & Shareholding" symbol: "519512" company: "Dr M Induscorp Ltd" canonical: "https://tapetide.com/stocks/519512" isin: "INE733B01016" bse_code: "519512" generated_at: "2026-11-05T01:51:31.732Z" --- # Dr M Induscorp (519512) Canonical page: https://tapetide.com/stocks/519512 ## Key Facts - **Revenue, period ended Jun 2026:** ₹112.1 Cr - **Net profit, period ended Jun 2026:** ₹1.12 Cr ## Company - **BSE code:** 519512 - **ISIN:** INE733B01016 - **In the F&O segment:** No ## Key Insights ### Weaknesses - Company might be capitalizing the interest cost ## Growth Rate Growth computed from the financial statements below. A window with no rate gives the reason instead of a figure. | Metric | Window | Growth | What it compares | | --- | --- | ---: | --- | | Revenue | 10Y | Zero base | compounded annual rate, Mar 2016 to Mar 2026: ₹0.00 Cr to ₹450 Cr. The starting figure is zero, so there is no rate. | | Revenue | 5Y | Irregular period | compounded annual rate, Mar 2021 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. | | Revenue | 3Y | Irregular period | compounded annual rate, Mar 2023 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. | | Revenue | 1Y | 69.81% | fiscal year to Mar 2026 vs the year to Mar 2025 | | Net profit | 10Y | Zero base | compounded annual rate, Mar 2016 to Mar 2026: ₹0.00 Cr to ₹0.00 Cr. The starting figure is zero, so there is no rate. | | Net profit | 5Y | Irregular period | compounded annual rate, Mar 2021 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. | | Net profit | 3Y | Irregular period | compounded annual rate, Mar 2023 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. | | Net profit | 1Y | Zero base | fiscal year to Mar 2026 vs the year to Mar 2025: ₹0.00 Cr to ₹0.00 Cr. The starting figure is zero, so there is no rate. | | Operating cash flow | 10Y | Turned negative | compounded annual rate, Mar 2016 to Mar 2026: ₹0.00 Cr to -₹4.00 Cr. A cash inflow at the start and an outflow at the end. | | Operating cash flow | 5Y | Irregular period | compounded annual rate, Mar 2021 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. | | Operating cash flow | 3Y | Irregular period | compounded annual rate, Mar 2023 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. | | Operating cash flow | 1Y | Turned negative | fiscal year to Mar 2026 vs the year to Mar 2025: ₹0.00 Cr to -₹4.00 Cr. A cash inflow at the start and an outflow at the end. | | Operating margin | 10Y | No sales | compounded annual rate, Mar 2016 to Mar 2026. Sales are zero or negative in one of the two periods, so there is no margin. | | Operating margin | 5Y | Irregular period | compounded annual rate, Mar 2021 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. | | Operating margin | 3Y | Irregular period | compounded annual rate, Mar 2023 to Mar 2026. A period in this window is not a full year or quarter, or the year-end changed, so the periods do not compare. | | Operating margin | 1Y | 0.00 pp | fiscal year to Mar 2026 vs the year to Mar 2025 | Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure. ## Financial Statements ### Quarterly Results Figures in ₹ crore unless the row name gives another unit. | Item | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 | | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Sales | 0.06 | 0.05 | 0.06 | 0.08 | 20.03 | 77.79 | 187 | 96.58 | 56.38 | 112 | | Expenses | 0.12 | 0.11 | 0.15 | 0.15 | 20.18 | 76.57 | 188 | 95.74 | 56.35 | 110 | | Operating Profit | -0.06 | -0.06 | -0.09 | -0.07 | -0.15 | 1.22 | -0.93 | 0.84 | 0.03 | 1.75 | | OPM % | -100% | -120% | -150% | -87.5% | -0.75% | 1.57% | -0.5% | 0.87% | 0.05% | 1.56% | | Other Income | 0.04 | 0.1 | 0.14 | 0.12 | 0.08 | 0.18 | 0.01 | 0 | 0.05 | 0 | | Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.02 | 0.02 | | Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0.05 | | Profit before tax | -0.02 | 0.04 | 0.05 | 0.05 | -0.07 | 1.4 | -0.92 | 0.79 | 0.05 | 1.68 | | Tax % | 0% | 0% | 0% | 0% | -57.14% | 22.14% | 0% | 0% | 40% | 33.33% | | Net Profit | -0.02 | 0.04 | 0.05 | 0.04 | -0.03 | 1.09 | -0.93 | 0.79 | 0.03 | 1.12 | The columns include both quarters and half years, as the company reported them. ### Profit & Loss Figures in ₹ crore unless the row name gives another unit. | Item | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 | | --- | ---: | ---: | ---: | ---: | ---: | | Sales | 0 | 0 | 0 | 265 | 450 | | Expenses | 0 | 1 | 0 | 265 | 450 | | Operating Profit | 0 | 0 | 0 | 0 | 0 | | OPM % | n/m | n/m | n/m | 0% | 0.1% | | Other Income | 0 | 0 | 0 | 0 | 0 | | Interest | 0 | 0 | 0 | 0 | 0 | | Depreciation | 0 | 0 | 0 | 0 | 0 | | Profit before tax | 0 | 0 | 0 | 0 | 0 | | Tax % | 0% | 22% | 0% | 16% | 18% | | Net Profit | 0 | 0 | 0 | 0 | 0 | | Dividend Payout % | 0% | 0% | 0% | 0% | 0% | n/m: Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. ### Balance Sheet Figures in ₹ crore unless the row name gives another unit. | Item | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Sep 2025 | | --- | ---: | ---: | ---: | ---: | ---: | | Equity Capital | 8 | 8 | 8 | 8 | 8 | | Reserves | -5 | -5 | -5 | -5 | -5 | | Borrowings | 0 | 0 | 0 | 2 | 2 | | Other Liabilities | 0 | 0 | 0 | 7 | 13 | | Total Liabilities | 3 | 3 | 2 | 12 | 18 | | Fixed Assets | 0 | 0 | 0 | 0 | 0 | | CWIP | 0 | 0 | 0 | 0 | 0 | | Investments | 0 | 0 | 0 | 0 | 0 | | Other Assets | 3 | 3 | 2 | 11 | 18 | | Total Assets | 3 | 3 | 2 | 12 | 18 | ### Cash Flow Figures in ₹ crore unless the row name gives another unit. | Item | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 | | --- | ---: | ---: | ---: | ---: | ---: | | Cash from Operating Activity | 0 | 0 | -2 | 0 | -4 | | Cash from Investing Activity | 0 | 0 | 0 | 0 | 0 | | Cash from Financing Activity | 0 | 0 | 0 | 2 | 3 | | Net Cash Flow | 0 | 0 | -1 | 2 | 0 | | Free Cash Flow | 0 | 0 | -2 | 0 | -4 | | CFO/OP | 0 | 0 | 577 | 750 | -1,396 | ### Ratios | Item | Mar 2016 | Mar 2017 | Mar 2024 | Mar 2025 | Mar 2026 | | --- | ---: | ---: | ---: | ---: | ---: | | Debtor Days | — | — | — | 0 | — | | Inventory Days | — | — | — | 0 | — | | Cash Conversion Cycle | — | — | — | 0 | — | | Working Capital Days | — | — | — | 3 | — | | ROCE % | — | 3% | — | 12% | — | ## Shareholding Pattern Not shown: Shareholding Pattern. Not this company's figures: left behind by an earlier update and not confirmed by the latest one. ## Frequently Asked Questions about Dr M Induscorp ### Where is Dr M Induscorp Ltd (519512) listed? Dr M Induscorp Ltd trades under code 519512 on the BSE. ## Company Information - **Face Value:** ₹10 --- Negative figures use an ASCII hyphen-minus (-) so they parse as numbers. Amounts are in Indian rupees; "Cr" is crore (10 million). Dates are Indian Standard Time. Financial statements, shareholding and filings are as reported by the company. Price, volume and 52-week levels are market data. Technical indicators are computed by Tapetide from daily prices. The Tapetide Score is Tapetide’s own analysis. Analyst ratings and forecasts are the published estimates of third-party analysts, not company statements. The AI sections are generated text. For research and information only, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser. Generated 5 Nov 2026, 07:21 IST.